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Edited by Jesus AvilaAbstract The Rho-family of small GTPases consists of essen-
tial regulators of neurite outgrowth, axonal pathﬁnding, and
dendritic arborization. Previous work has demonstrated in non-
neuronal cell types that Smurf1, an E3 ubiquitin ligase, regulates
cell polarity and protrusive activity via PKCf-dependent recruit-
ment to cellular protrusion sites, and subsequent ubiquitination
and proteasomal degradation of RhoA. In this study, we show
that Smurf1 enhances neurite outgrowth in Neuro2a neuroblas-
toma cells. We demonstrate that RhoA is ubiquitinated, and that
Smurf1 and RhoA physically interact in vivo. Interestingly,
Smurf1 overexpression in Neuro2a cells dramatically reduces
RhoA protein levels during dibutyric cyclic AMP, but not reti-
noic acid induced neurite outgrowth. This Smurf1-dependent
reduction in RhoA protein levels was abrogated using the general
proteasome inhibitor MG132, suggesting that RhoA is targeted
for ubiquitination and degradation via Smurf1. Together, our
data suggest that localized regulation of diﬀerent subsets of
Rho GTPases by speciﬁc guidance signals results in an intracel-
lular asymmetry of RhoA activity, which could regulate neurite
outgrowth and guidance.
 2005 Federation of European Biochemical Societies.
Published by Elsevier B.V. All rights reserved.
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The proper molecular regulation of neurite network forma-
tion is essential for correct neuronal signaling and function
[1,2]. In order to form and maintain proper axonal/dendritic
networks, it is extremely important that neurites initially aris-
ing from the cell body of neurons are in the correct location
and establish the appropriate connections [3,4]. However, the
molecular mechanisms that control the outgrowth and pattern-
ing of neurites are largely unknown.
Recently, several studies have implicated the Rho family
members (Rho, Rac, and Cdc42) in the regulation of neurite
outgrowth and patterning [5–8]. These studies have shown that
the Rho family can regulate every process in a neuron that in-
volves plasticity of the cytoskeleton, including cellular func-*Corresponding author. Fax: +1 713 677 7512.
E-mail address: mliu@ibt.tamhsc.edu (M. Liu).
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doi:10.1016/j.febslet.2004.12.074tions such as control of neuronal polarity, neuronal
migration, growth cone guidance, and proper function of syn-
apses. Importantly, Rho GTPases regulate the motility of all
neurite terminals, thus aﬀecting both axonal guidance and
the shape of dendritic arborizations [9–11]. In most neuronal
cell types, RhoA mediates neurite retraction via its activation
of myosin proteins that generate force against the actin cyto-
skeleton [12]. On the other hand, the other two members of
the Rho-family, Rac1 and Cdc42, have been shown to play
opposing roles to RhoA by promoting neurite outgrowth via
their downstream eﬀectors: PAK, p35, Cdk5, etc. [13]. It is
poorly understood exactly how the Rho family of small GTP-
ases work in synchrony to regulate neurite outgrowth. It is
hypothesized that guidance decisions, either attractive or
repulsive, could be based on localized activation of diﬀerent
subsets of Rho GTPases (Rho, Rac, and/or Cdc42) by speciﬁc
guidance signals, and the resulting intracellular asymmetry of
GTPase activity could regulate the cytoskeleton re-organiza-
tion in response to speciﬁc extracellular signals in a particular
fashion.
Smurf1, an E3 ubiquitin ligase for both the BMP receptor
activated Smad1/5 and the inhibitory Smad7 [14], has been
shown to regulate osteoblast diﬀerentiation, bone formation,
and myogenic diﬀerentiation [15–17]. It was recently demon-
strated that Smurf1 targets RhoA for ubiquitination and sub-
sequent proteasomal degradation in HEK293T cells [18,19].
This targeting occurred at discreet regions of the cell, leading
to the activation of Rac1 and Cdc42, and the formation of
membrane microspikes. Thus, Smurf1 generates an intracellu-
lar asymmetry of GTPase activity, thereby regulating cell
polarity and cytoskeleton rearrangements. Interestingly, the
mechanisms controlling cytoskeletal organization in non-
neuronal cell types (i.e., membrane microspike, lamellipodia,
stress ﬁber formation) is similar to that observed in neuronal
cells (i.e., neurite bud emergence, elongation, and retraction)
[20]. Because the Rho-family GTPases perform essential roles
in regulating cytoskeletal-dependent neurite outgrowth, we
hypothesize that the E3 ubiquitin ligase, Smurf1, could de-
grade RhoA during neurite formation, thus allowing positive
neurite outgrowth to occur permissively via Rac1 and Cdc42
activity. Using Neuro2a neuroblastoma cells, we demonstrate
that Smurf1 enhances neurite outgrowth, and that Smurf1
and RhoA physically interact in Neuro2a cells. Overexpres-
sion of Smurf1 dramatically reduces RhoA protein levels dur-
ing dibutyric cyclic AMP- (dbcAMP), but not retinoic acid
(RA)-induced neurite outgrowth. Furthermore, we demon-
strate that RhoA is ubiquitinated in the presence of Smurf1
in Neuro2a cells. The Smurf1-dependent reduction of RhoAblished by Elsevier B.V. All rights reserved.
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inhibitor MG132, suggesting that RhoA is targeted for ubiq-
uitination and degradation via Smurf1. Together our data
suggest that localized regulation of Rho GTPases by speciﬁc
signaling pathways results in an intracellular asymmetric dis-
tribution of Rho GTPases.able 12. Materials and methods
2.1. DNA constructs
The genes encoding human Smurf1 and the dominant negative
Smurf1 C710A mutant were cloned into the pCMVTag2B vector with
an N-terminal FLAG tag. RhoA mammalian expression vectors were
constructed as described previously [21].
2.2. Cell culture, transfection, and neuritogenesis
Neuro2a cells were maintained in Dulbeccos modiﬁed Eagles med-
ium (Invitrogen) supplemented with 10% fetal bovine serum (Hyclone).
Induction of neurite outgrowth using dbcAMP and RA was performed
as previously described [22,23]. MG132 was added to the Neuro2a cells
4 h prior to harvesting as previously published [24]. Cell transfection
was performed using LipofectAMINE (Invitrogen) according to the
manufacturers instructions.
2.3. Neurite outgrowth measurements
Phase contrast images of Neuro2a cells were viewed at 200· mag-
niﬁcation, and images were captured on a CCD camera mounted on
a Nikon Eclipse TS100 microscope using SPOT Advanced Imaging
Software. Cells were scored for the percentage of cells expressing
neurites, average number of neurites per cell, and average length
of neurites. Cells with neurites were deﬁned as cells that possessed
at least one neurite more than 1/2 the cell body diameter in length.
The data presented are the means of three individual transfected
10 cm2 dishes, and are representative of at least three independent
experiments. Rhodamine–phalloidin staining for ﬂuorescence visual-
ization of cell morphology was performed as previously described
[21].
2.4. Immunoprecipitation and Western blotting
Immunoprecipitations and Western blotting were performed as pre-
viously described [21,24].
2.5. Reverse transcriptase polymerase chain reaction (RT-PCR)
Total RNAs from Neuro2a cells were obtained using Trizol (Invit-
rogen) puriﬁcation according to the manufacturers instructions. The
amount of RNA obtained was determined by both spectrometric
measurement at 260 nm and by agarose gel electrophoresis. The
RT-PCR was carried out with 3 lg total RNA. The PCR ampliﬁca-
tion of endogenous RhoA and actin were carried out with primers
that speciﬁcally ampliﬁed these cDNAs. The PCR products were
visualized in 2% agarose/TAE gels and stained with ethidium
bromide.eurite outgrowth measurements in Neuro2a transfected cells
onstruct % Cells
w/neurites
# Neurites/cell Neurite
length (lm)
ector 47 ± 2.1 2.4 ± 0.04 57 ± 4.0
hoA 28 ± 4.2 1.5 ± 0.09 34 ± 0.7
hoA G14V 25 ± 7.1 1.4 ± 0.01 35 ± 4.7
murf1 62 ± 5.7 3.1 ± 0.18 67 ± 12
murf1 C710A 23 ± 1.4 1.9 ± 0.11 35 ± 7.4
murf1 + RhoA 44 ± 3.5 2.3 ± 0.29 56 ± 0.8
murf1 + RhoA G14V 40 ± 2.8 2.1 ± 0.18 54 ± 1.1
murf1 C710A + RhoA 24 ± 4.2 1.4 ± 0.14 30 ± 2.5
murf1 C710A + RhoA
14V
25 ± 9.9 1.4 ± 0.15 32 ± 10.6
ells with neurites were deﬁned as cells that possessed at least one
eurite more than 1/2 the cell body diameter in length. The data pre-
ented are the means of three individual transfected 10 cm2 dishes, and
are representative of at least three independent experiments.3. Results
3.1. Smurf1 E3 ubiquitin ligase promotes neurite outgrowth in
Neuro2a cells
Both the TGF-b signaling pathway and the Rho-family of
small GTPases have been implicated in the regulation of neu-
rite outgrowth [5,13,25–27]. Recently, the E3 ubiquitin ligase,
Smurf1, has been shown to target Smad proteins as well as
RhoA for ubiquitination and subsequent proteolysis [18,19].
Because several previous studies have implicated the TGF-b
signaling pathways and the Rho-family as important regula-
tors of neurite outgrowth, we examined if Smurf1 plays a role
in the regulation of this process.In order to test if Smurf1 regulates neurite outgrowth, we co-
expressed Smurf1 (WT or C710A dominant negative mutant)
and RhoA (WT or G14V dominant active mutant) in Neuro2a
neuroblastoma cells, and quantiﬁed neurite outgrowth 24 h
after transfection. As shown in Table 1, both wild-type RhoA
and constitutively active RhoA-G14V overexpression resulted
in markedly reduced neurite outgrowth when compared to
control cells, correlating with observations from previous stud-
ies [13,28]. Interestingly, exogenous expression of wild-type
Smurf1 led to a statistically signiﬁcant increase in neurite out-
growth when compared to control cells (Table 1 and Fig. 1A
and B). On the other hand, neurite outgrowth in cells express-
ing the mutant form of Smurf1 (C710A) was reduced to a sim-
ilar level as cells expressing either RhoA or RhoA-G14V,
suggesting that Smurf1 C710A has dominant negative eﬀects
on neurite formation and outgrowth. Smurf1 C710A is a cat-
alytically inactive mutant of Smurf1 that loses the E3 ligase
activity [19]. The dominant negative eﬀect of Smurf1 C710A
on neurite outgrowth is probably induced by blocking
Smurf1-mediated degradation of RhoA in the cells. In co-
expression experiments, exogenous expression of the wild-type
Smurf1, but not the dominant negative Smurf1 mutant, abro-
gated the negative eﬀects on neurite outgrowth induced by
RhoA (wild-type or constitutively active) expression. Because
both TGF-b signaling and the Rho-family have been shown
to regulate neurite outgrowth, and Smurf1 is a regulator of
both signaling pathways, we decided to examine what role
Smurf1 plays in regulating Rho-family-dependent neurite
outgrowth.
3.2. RhoA is ubiquitinated and interacts with Smurf1 in vivo
Because our data and others have demonstrated that RhoA
inhibits neurite outgrowth [13,28], and we demonstrate that
Smurf1 increases neurite outgrowth in Neuro2a cells, we
sought to determine if this neurite modulation occurs via a
Smurf1 mediated RhoA degradation. Smurf1 E3 ubiquitin li-
gase has previously been shown to directly interact with RhoA,
targeting it for ubiquitination and proteasome-dependent deg-
radation in HEK293T cells [18,19]. In order to determine if
RhoA is ubiquitinated in Neuro2a cells, we exogenously
expressed RhoA-FLAG alone or co-expressed it with an
HA-tagged ubiquitin in Neuro2a cells. Total cell lysates were
subjected to immunoprecipitation using an anti-FLAGT
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Fig. 2. RhoA is ubiquitinated and physically interacts with Smurf1 in
Neuro2a cells. (A) Neuro2a cells were transfected with RhoA-FLAG
alone or together with Ubiquitin-HA. Lysates were collected 24 h post-
transfection and immunoprecipitated with an anti-RhoA antibody.
Western blot analyze was performed on the immuno-complex using an
anti-HA antibody. Total RhoA and total actin levels were detected
using anti-RhoA and anti-actin antibodies. (B) Neuro2a cells were
transfected with an empty vector as a control, RhoA, or co-transfected
with RhoA and Smurf1-FLAG. Lysates were collected 24 h post-
transfection and immunoprecipitated with an anti-RhoA antibody.
Western blot analysis was performed on the immuno-complex using an
anti-FLAG antibody. Total actin and total RhoA levels were detected
using anti-actin and anti-RhoA antibodies.
Fig. 1. Smurf1 promotes neurite outgrowth in Neuro2a cells.
(A) Smurf1 cDNA or an empty vector as a control was exogenously
expressed in Neuro2a cells. The cells were grown for 24 h post-
transfection and cell morphology was observed under a phase contrast
microscope or a ﬂuorescent microscope using rhodamine–phalloidin
staining. (B) Quantiﬁcation of percentage of cells expressing neurites in
vector versus Smurf1 transfected Neuro2a cells as observed with phase
contrast microscopy. Cells with neurites were deﬁned as cells that
possessed at least one neurite more than 1/2 the cell body diameter in
length. The data presented are the mean of three individual transfected
10 cm2 dishes, and are representative of at least three independent
experiments (\ denotes p value < 0.05).
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antibody. As shown in Fig. 2A, no band was detectable in the
control lane where RhoA was expressed alone. In contrast, a
large smear is visible both above and below the RhoA band
when RhoA is co-expressed with HA-tagged ubiquitin, demon-
strating that RhoA is ubiquitinated in Neuro2a cells.
To investigate if Smurf1 is an E3 ubiquitin ligase for RhoA
in Neuro2a cells, we ﬁrst determined if RhoA and Smurf1
physically interact in vivo. Cell lysates from cells transfected
with empty vector, RhoA, or co-expressing RhoA and
Smurf1-FLAG were immunoprecipitated using an anti-RhoA
antibody, and Western blotting was performed using an anti-
FLAG antibody (Fig. 2B). As a control, Smurf1 was undetect-
able in samples from cells not transfected with Smurf1 cDNA.
However, Smurf1 was co-precipitated with RhoA as indicated
by a band of the correct size in immunoprecipitations from ly-
sates in which cells co-expressed both RhoA and Smurf1. Ta-
ken together, our data demonstrate that, in neuronal cells,
RhoA is ubiquitinated and that Smurf1 physically interacts
with RhoA in vivo.
3.3. Smurf1 promotes degradation of RhoA during dibutyric
cyclic AMP diﬀerentiation of Neuro2a cells
As our data show that RhoA is ubiquitinated and that both
RhoA and Smurf1 physically interact in vivo, we next exam-
ined whether exogenous expression of Smurf1 E3 ubiquitin li-gase in neuronal cells aﬀects the steady state levels of the RhoA
protein. Neuro2a cells were transfected with Smurf1, Smurf1
C710A, or an empty vector as a control, and harvested after
24 h. Lysates were analyzed by Western blotting using an
anti-RhoA antibody. As demonstrated in Fig. 3A, RhoA levels
did not show a signiﬁcant change between lysates containing
Smurf1, Smurf1 C710A, or control vector, suggesting that un-
der normal proliferative growth, Smurf1 does not exhibit a
major eﬀect on RhoA protein levels.
Although Smurf1 does not signiﬁcantly aﬀect RhoA stability
under normal growth conditions, we examined if Smurf1 is
capable of regulating RhoA stability during induction of neu-
ronal outgrowth with chemical inducers. dbcAMP and RA are
capable of inducing neurite outgrowth and diﬀerentiating a
number of neuronal cell types [22,29,30]. dbcAMP is a stable
membrane soluble cAMP analog that is not degraded by phos-
phodiesterases, and serves to diﬀerentiate neuronal cell types
by mimicking the eﬀects of cAMP, thereby activating down-
stream targets of cAMP such as protein kinase A [31]. RA sig-
nals neuronal diﬀerentiation by directly activating retinoid
nuclear receptors which then upregulate the transcription of
a number of proteins involved in cell diﬀerentiation [32]. Neu-
ro2a cells were transfected with Smurf1, Smurf1 C710A, or an
Fig. 3. Smurf1 regulates the steady state level of RhoA protein during
dibutyric cyclic AMP, but not RA-induced neuritogenesis. (A) Total
Neuro2a cell lysates collected from cells transfected with an empty
vector, Smurf1, or Smurf1 C710A were immunoblotted with an anti-
RhoA antibody. An anti-actin antibody was utilized as a loading
control. (B) Neuro2a cells transfected with an empty vector, Smurf1-
FLAG, or Smurf1 C710A-FLAG were induced to form neurites with
dibutyric cyclic AMP or RA, and lysates were collected at t = 0, 1, 2,
and 4 h after treatment. Western blot analyses of the lysates were
performed with an anti-RhoA antibody. Anti-FLAG and anti-actin
antibodies were utilized as controls.
Fig. 4. RhoA protein stability is regulated during dbcAMP induced
neuritogenesis via Smurf1-dependent ubiquitination and subsequent
proteolytic degradation. (A) Neuro2a cells were transfected with
Smurf1-FLAG cDNA and induced to form neurites with dbcAMP.
Total cellular RNA and protein were collected using Trizol puriﬁca-
tion at 0, 1, 2, and 4 h after dbcAMP treatment. Western blotting using
an anti-FLAG antibody was utilized in order to detect Smurf1
expression. RT-PCR using primers speciﬁc for either RhoA or actin
was performed. (B) Neuro2a cells transfected with an empty vector,
Smurf1, or Smurf1 C710A were treated with dbcAMP. Lysates were
collected at three time points: 0 h, 2 h after treatment, and 2 h after
treatment in the presence of the proteasome inhibitor MG132. Western
blotting was performed using an anti-RhoA antibody and an anti-actin
antibody as a control.
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added to the cell cultures and total cell lysates were collected
at 0, 1, 2, 4 h, and Western blotting for RhoA steady state pro-
tein levels was performed using an anti-RhoA antibody. As
demonstrated in Fig. 3B, after dbcAMP addition to the cells
transfected with an empty vector, RhoA levels peaked after
1 h treatment, and then dropped to basal levels at 2 and 4 h.
In sharp contrast, in cells transfected with Smurf1, RhoA lev-
els were signiﬁcantly reduced below basal levels at 1, 2, and 4 h
of dbcAMP treatment. As a control, RhoA expression was
similar in cells expressing Smurf1 C710A mutant protein to
cells expressing the vector only. These data suggest that
Smurf1 regulates RhoA steady state protein levels during
dbcAMP-induced neurite outgrowth of Neuro2a cells.
During RA-induced neurite outgrowth of Neuro2a cells
transfected with an empty vector, RhoA levels remained con-
stant 1 h after treatment, and dropped oﬀ at 2 and 4 h (Fig.
3B). Interestingly, lysates from both Smurf1 and Smurf1
C710A transfected cells exhibited similar RhoA expression
patterns when compared to the vector control, suggesting that
RA-induced RhoA stability, under the conditions tested, is
independent of exogenous Smurf1 expression.
While our data suggest that RhoA steady state protein levels
are reduced in a Smurf1-dependent manner, it does not rule out
the possibility that this regulation occurs at the transcriptional
level. In order to determine at what level Smurf1 regulates the
expression of RhoA, we diﬀerentiated Smurf1-FLAG transfec-
ted Neuro2a cells with dbcAMP and collected lysates at 0, 1, 2,
and 4 h after treatment. Western blotting using an anti-FLAGantibody conﬁrmed the presence of Smurf1 in the samples. RT-
PCR was performed using primers speciﬁc for RhoA or actin.
As shown in Fig. 4A, the presence of Smurf1 does not aﬀect
RhoA mRNA levels, suggesting that the Smurf1-dependent
decrease in RhoA as observed in Fig. 3B does not occur at
the transcription level.
Our data suggest that RhoA protein stability is regulated by
Smurf1 during dbcAMP induction of neurite outgrowth in
Neuro2a cells. Because Smurf1 is an E3 ubiquitin ligase, it is
likely that RhoA is regulated at the post-translational level
by Smurf1-mediated ubiquitination and subsequent proteaso-
mal degradation. In order to test this hypothesis, we examined
the levels of RhoA protein during dbcAMP treatment in the
presence of the general proteasome blocker, MG132. Neuro2a
cells were transfected with Smurf1, Smurf1 C710A, or an
empty vector as a control. Cells were grown for 48 h, and ly-
sates with no dbcAMP treatment were collected (t = 0).
dbcAMP was added to the remaining cells, which were grown
with or without the presence of the proteasome blocker,
MG132. The cells were harvested at 2 h after addition of
dbcAMP. Immunoblots were performed on the lysates using
anti-RhoA antibodies. In Smurf1 cell lysates at 2 h after treat-
ment, RhoA protein levels went from undetectable without
MG132, to as high as control levels in the presence of
MG132 (Fig. 4B). No eﬀect was observed with the Smurf1
C710A mutant (Fig. 4B). By inhibiting the proteasome and
rescuing the Smurf1-mediated reduction in RhoA protein lev-
els, this experiment demonstrates that RhoA is targeted for
proteasome-dependent degradation via Smurf1-mediated
ubiquitination during dbcAMP diﬀerentiation.4. Discussion
Both the Rho family of small GTPases and the TGFb signal-
ing pathways have been implicated in regulating neurite out-
growth, axon elongation, and dendrite morphology and
branching [5,13,33,34]. In addition, one recent study has dem-
B. Bryan et al. / FEBS Letters 579 (2005) 1015–1019 1019onstrated that Smurf1, a HECT domain E3 ubiquitin ligase
that is known to regulate the stability of Smad proteins, is
capable of regulating cell polarity and protrusive activity in
non-neuronal cells lines via regulation of RhoA stability
[18,19]. Considering the general lack of understanding in
how the Rho-family of small GTPases coordinately regulates
neurite outgrowth, branching, and retraction, and the fact that
Smurf1 has been recently shown to regulate RhoA stability
and cytoskeletal rearrangements in non-neuronal cell types,
we evaluated whether Smurf1 plays a role in regulating similar
processes in neuronal cells. Together our results indicate that
Smurf1 promotes neurite outgrowth in Neuro2a neuroblas-
toma cells through regulation of the Rho-family. We observed
that in Neuro2a cells, this regulation speciﬁcally occurred via
ubiquitination/proteasome-dependent degradation of RhoA
during dbcAMP induced neuritogenesis. The observations in
this study have added to the breath of research implicating
the Rho-family of small GTPases in the regulation of all as-
pects of neurite outgrowth by showing that Smurf1-mediated
degradation of RhoA protein levels plays a major role in
neuritogenesis.
A considerable amount of research has been performed in or-
der to understand the molecular mechanisms controlling neu-
rite outgrowth and guidance, however, little is actually
known about the precise signaling mechanisms regulating this
process. This research has uncovered one very important aspect
of the molecular mechanisms of how the Rho family of small
GTPases works in synchrony to regulate neurite outgrowth in
order to form neurites and potentially regulate neuronal guid-
ance. Our ﬁndings, which support a model that an intracellular
asymmetry of Rho-GTPases regulates neurite outgrowth, could
have signiﬁcant implications with respect to the present under-
standing of neurite outgrowth and guidance.
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